Imbrium Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Imbrium Therapeutics's estimated annual revenue is currently $5.7M per year.
- Imbrium Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Imbrium Therapeutics has 37 Employees.
- Imbrium Therapeutics grew their employee count by 0% last year.
Imbrium Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Imbrium Therapeutics?
Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Stamford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.7M | 37 | -3% | N/A |
#2 | $7.5M | 37 | -16% | N/A |
#3 | $15M | 37 | 6% | N/A |
#4 | $6.9M | 37 | 0% | N/A |
#5 | $8.6M | 37 | 6% | N/A |